← Back to headlines
Stifel Cuts Medtronic (MDT) Target to $95 Citing MiniMed IPO Effects
Stifel has lowered its price target for Medtronic (MDT) to $95, attributing the adjustment to the anticipated effects of the MiniMed IPO.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Italy Extends Diesel Fuel Tax Cut Through Early September
23m ago
Cisco Abandons Traditional Hardware Restrictions to Pursue AI Infrastructure Boom
33m ago
Executives at Itron and Lyft Sell Significant Company Stock Holdings
35m ago
Senior Official Firmly Rejects External Political Pressure and Influence Attempts
35m ago